No differences in calcium-binding protein immunoreactivity in the posterior cingulate and visual cortex: Schizophrenia and controls

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 630-639

  Wheeler, David G ^a,b   Dixon, Gavin ^a,b   Harper, Clive G ^a,b  

^a Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

BA 23; BA 30; Calbindin; Calcium binding proteins; Posterior cingulate cortex; Schizophrenia; Visual cortex

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY;

ADULT; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CADAVER; CELL DENSITY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MALE; NISSL STAINING; NUCLEOLUS; SCHIZOPHRENIA; VISUAL CORTEX;

ADULT; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CASE-CONTROL STUDIES; CELL COUNT; FEMALE; GYRUS CINGULI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POSTMORTEM CHANGES; SCHIZOPHRENIA; VISUAL CORTEX;

EID: 33646114514     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.041     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., and Trojanowski J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152 5 (1995) 738-748
3. Beasley C.L., and Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24 3 (1997) 349-355
4. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52 7 (2002) 708-715
5. Benes F.M. Post-mortem structural analyses of schizophrenic brain: study designs and the interpretation of data. Psychiatr Dev 6 3 (1988) 213-226
6. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31 2-3 (2000) 251-269
7. Brun A., and Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 5 5 (1981) 549-564
8. Byrum C.E., Thompson J.E., Heinz E.R., Krishnan K.R., and Tien R.D. Limbic circuits and neuropsychiatric disorders. Functional anatomy and neuroimaging findings. Neuroimaging Clin N Am 7 1 (1997) 79-99
9. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58 6 (2001) 545-553
10. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., and Everall I. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 51 5 (2002) 377-386
11. Daviss S.R., and Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 59 1-2 (1995) 81-96
12. Dixon G., Dissanaike S., and Harper C.G. Parvalbumin-immunoreactive neurons in the human anteroventral thalamic nucleus. NeuroReport 11 1 (2000) 97-101
13. Eyles D.W., McGrath J.J., and Reynolds G.P. Neuronal calcium-binding proteins and schizophrenia. Schizophr Res 57 1 (2002) 27-34
14. Fairen A., DeFelipe J., and Regidor J. Nonpyramidal neurons: general account. In: Alan P., Edward G., and Jones (Eds). Cerebral cortex: cellular components of the cerebral cortex (1984), Plenum Press, London 201-253
15. Gundersen H.J. The nucleator. J Microsc 151 1 (1988) 3-21
16. Harding A., Halliday G., and Cullen K.M. Practical considerations for the use of the optical dissector in estimating neuronal number. J Neurosci Method 51 (1994) 83-89
17. Hill C., Keks N., Roberts S., Opeskin K., Dean B., MacKinnon A., and Copolov D. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 153 4 (1996) 533-537
18. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 4 (1981) 577-580
19. Jones E.G. Neurogliaform or spider-web cells. In: Alan P., Edward G., and Jones (Eds). Cerebral cortex: cellular components of the cerebral cortex (1984), Plenum Press, London 409-418
20. Kalus P., Senitz D., and Beckmann H. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res 75 1 (1997) 49-59
21. Karson C.N., Casanova M.F., Kleinman J.E., and Griffin W.S. Choline acetyltransferase in schizophrenia. Am J Psychiatry 150 3 (1993) 454-459
22. Keefe R.S., Mohs R.C., Losonczy M.F., Davidson M., Silverman J.M., Kendler K.S., Horvath T.B., Nora R., and Davis K.L. Characteristics of very poor outcome schizophrenia. Am J Psychiatry 144 7 (1987) 889-895
23. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry. 2004 9(6):609-620, 544.
24. Kyosseva S.V., Elbein A.D., Griffin W.S., Mrak R.E., Lyon M., and Karson C.N. Mitogen-activated protein kinases in schizophrenia. Biol Psychiatry 46 5 (1999) 689-696
25. Mikkonen M., Soininen H., and Pitkanen A. Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex. J Comp Neurol 388 1 (1997) 64-88
26. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazlett E.A., and Buchsbaum M.S. Volume of the cingulate and outcome in schizophrenia. Schizophr Res 72 2-3 (2005) 91-108
27. Morris R., Paxinos G., and Petrides M. Architectonic analysis of the human retrosplenial cortex. J Comp Neurol 421 1 (2000) 14-28
28. Mountcastle V.B. The columnar organization of the neocortex. Brain 120 Pt 4 (1997) 701-722
29. Nimchinsky E.A., Vogt B.A., Morrison J.H., and Hof P.R. Neurofilament and calcium-binding proteins in the human cingulate cortex. J Comp Neurol 384 4 (1997) 597-620
30. Ohnuma T., Kimura M., Takahashi T., Iwamoto N., and Arai H. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin Neurosci 51 1 (1997) 9-15
31. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., and Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57 2-3 (2002) 127-138
32. Reynolds G.P., and Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia. J Chem Neuroanat 22 1-2 (2001) 95-100
33. Reynolds G.P., Zhang Z.J., and Beasley C.L. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res Bull 55 5 (2001) 579-584
34. Reynolds G.P., Beasley C.L., and Zhang Z.J. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J Neural Transm 109 5-6 Special Issue SI (2002) SS1-SS889
35. Reynolds G.P., Abdul-Monim Z., Neill J.C., and Zhang Z.J. Calcium binding protein markers of GABA deficits in schizophrenia - postmortem studies and animal models. Neurotox Res 6 1 (2004) 57-62
36. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52 10 (1995) 805-818 (discussion 819-820)
37. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol 392 3 (1998) 402-412
38. Somogyi P., and Cowey A. Double bouquet cells. In: Alan P., Edward G., and Jones (Eds). Cerebral cortex: cellular components of the cerebral cortex (1984), Plenum Press, London 337-360
39. Tooney P.A., and Chahl L.A. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 273-278
40. Vogt B.A., Nimchinsky E.A., Vogt L.J., and Hof P.R. Human cingulate cortex - surface features, flat maps, and cytoarchitecture. J Comp Neurol 359 3 (1995) 490-506
41. Woo T.U., Miller J.L., and Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 154 7 (1997) 1013-1015
42. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 55 1-2 (2002) 1-10